Skip to main content
S&P 5007,591.70-0.58%DOW52,064.10-0.60%NASDAQ26,081.72-0.65%BTC$76,759.00-1.92%ETH$2,449.71-0.78%GOLD$4,364.00-0.98%OIL$103.08+0.59%
Smart Investors Daily
IL

NASDAQ · ILMN

Illumina, Inc.

Healthcare · Medical - Diagnostics & Research

$205.00

Down-$3.73 (-1.82%)

Updated Sep 10, 2026, 11:30 PM

SID Score

6.7/10

Composite research score

Smart Money

58/100

Neutral

Market cap
20.84B
P/E ratio
30.27
Dividend yield
0.00%
52-week range
$88.00 – $231.81
Volume
1.71M
Avg. volume
1.79M

Price performance

ILMN price history

1M range · 19 trading sessions · Daily adjusted prices

ILMN closed at $205.00 after 19 trading sessions, up 6.42% for the selected period.

Last close
$205.00
Period change
+6.42%
Period low
$188.29
Period high
$227.69
Daily close
View OHLC price history
ILMN OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 9, 2026$211.625$212.18$203.6048$205.001.71M
Sep 8, 2026$218.65$219.45$210.15$211.061.82M
Sep 4, 2026$216.74$219.575$213.95$218.221.75M
Sep 3, 2026$213.24$221.76$210.94$221.661.72M
Sep 2, 2026$208.62$214.98$207.13$213.251.77M
Sep 1, 2026$212.36$213.385$206.82$207.131.5M
Aug 31, 2026$213.74$214.90$208.98$213.632.02M
Aug 28, 2026$224.73$225.095$214.61$215.591.79M
Aug 27, 2026$225.49$231.81$224.03$227.691.94M
Aug 26, 2026$220.78$227.70$220.00$224.841.71M
Aug 25, 2026$224.00$226.84$217.39$224.991.92M
Aug 24, 2026$215.98$223.97$212.37$223.222.25M
Aug 21, 2026$212.40$220.43$208.50$219.401.92M
Aug 20, 2026$200.302$220.32$200.302$213.243.28M
Aug 19, 2026$193.51$205.16$192.68$205.002.09M
Aug 18, 2026$192.13$192.83$187.541$188.291.19M
Aug 17, 2026$191.01$193.85$188.94$193.135995.96K
Aug 14, 2026$190.05$192.775$188.0002$190.89993.08K
Aug 13, 2026$194.00$194.50$187.44$192.641.06M

Latest ILMN news

The latest Smart Investors Daily articles mentioning ILMN.

Stock researchCompany · Overview

ILMN research

Overview

Company profile and research snapshot.

Company profile

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$115.25
Implied upside
—
Analysts
28
ILMN recent ratings
DateFirmRatingTarget
Sep 9, 2026UBSBuy—
Sep 3, 2026Argus ResearchBuy—
Aug 3, 2026Canaccord GenuityHold—
Aug 3, 2026Piper SandlerOverweight—
Aug 3, 2026CitigroupSell—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 5, 2026

Illumina (ILMN) Stock Looks Priced For Growth More Than Value

Illumina stock has delivered a very strong 1 year return, yet its valuation checks pull in different directions, with an intrinsic value estimate pointing to upside while market based multiples suggest the shares are not cheap. The result is a stock that has re-rated sharply without a clear consensus on whether the current price offers much room for error. Illumina has returned 120.6% over the past year, which puts extra focus on whether recent gains already reflect optimistic...

Yahoo · Sep 5, 2026

Could Illumina’s Novacyt Collaboration Framework Quietly Reshape Its Clinical Sequencing Narrative (ILMN)?

In September 2026, Novacyt S.A. announced it had entered into a five-year Master Collaboration Agreement with Illumina, creating a framework for separate project-based deals in product development and commercial collaboration. This structure gives Illumina a flexible way to tap Novacyt’s complementary expertise without committing upfront capital to specific programs, potentially broadening future genomic applications. We’ll now examine how this new Master Collaboration framework with...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By